Why the study?
Does surgical revascularization reduce cardiac death or acute myocardial infarction compared to percutaneous revascularization in diabetics with stable coronary artery disease?
Does surgical revascularization reduce cardiac death or acute myocardial infarction compared to percutaneous revascularization in diabetics with stable coronary artery disease?
The choice between surgical and percutaneous revascularization in diabetic patients with stable CAD remains complex, as current evidence does not definitively favor one strategy for preventing cardiac death or MI.
Revascularization choice in diabetic stable CAD remains uncertain; leaves open the need for definitive randomized trials.
Diabetes mellitus is associated with well-known increases in cardiovascular morbidity and mortality. In diabetics with stable coronary artery disease, the best therapeutic option is widely discussed. Current studies comparing surgical to percutaneous revascularization have been unable to definitely demonstrate any significant advantage of one strategy over the other regarding the prevention of cardiac death or acute myocardial infarction. Therefore, even taking into account clinical and angiographic information as well as the risks determined by each type of treatment, the decision regarding the best therapeutic strategy in diabetics with stable coronary artery disease is still complex.
No takes yet. Share an insight, caveat, or question.
Rocha et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: